Dexmedetomidine
- Product NDC
- 70860-605
- 11-digit product format
- 708600605
- Labeler code
- 70860
- Product ID
- 70860-605_f9e6c4d4-3ea1-4424-be4a-5687c5d5675a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- dexmedetomidine
- Dosage form
- INJECTION, SOLUTION, CONCENTRATE
- Route
- INTRAVENOUS
- Labeler
- Athenex Pharmaceutical Division, LLC.
- Application
- ANDA209065
- Marketing category
- ANDA
- Marketing start
- 2018-03-01
- Marketing end
- 0000-00-00
- Substance
- DEXMEDETOMIDINE HYDROCHLORIDE
- Active strength
- 100 ug/mL
- Pharmacologic classes
- Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70860-605-02 | 70860060502 | 10 VIAL in 1 CARTON (70860-605-02) > 2 mL in 1 VIAL (70860-605-41) | 10 vial | 2018-03-01 | 0000-00-00 | No | No | Current |
| 70860-605-03 | 70860060503 | 25 VIAL in 1 CARTON (70860-605-03) > 2 mL in 1 VIAL (70860-605-41) | 25 vial | 2018-03-01 | 0000-00-00 | No | No | Current |